News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MultiCell Technologies Inc. (EXTI) Release: Dr. Parkinson To Address 7th Annual Conference On Drug-Drug Interactions



10/19/2005 5:11:16 PM

MultiCell Technologies, Inc. (OTCBB:EXTI) announced today that Dr. Andrew Parkinson, founder and Chief Executive Officer of XenoTech, the Company's licensee, will be a featured speaker at the 7th Annual Conference on Drug-Drug Interactions to be held in San Diego from June 14 - 16, 2004.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES